Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Small, specific inhibitors of VLA4-mediated cell adhesion from Biogen

March 13, 1997

Improved immunomodulating agent described by SKB

March 13, 1997

Cell adhesion inhibitors disclosed by Nippon Shinyaku

March 12, 1997

Gelatinase inhibitors prepared by Ono

March 11, 1997

MMP inhibitors from Ono

March 10, 1997

U.S. patent covers Immunex's TNFR

March 7, 1997

IVAX receives approval for generic NSAID

March 6, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Protein kinase inhibitors reported by Roche

March 5, 1997

Teva's Tolmetin approved

March 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...